3-Hydroxyacyl-CoA dehydrogenase (HAD) deficiency replaces short-chain hydroxyacyl-CoA dehydrogenase (SCHAD) deficiency as well as medium- and short-chain hydroxyacyl-CoA dehydrogenase (M/SCHAD) deficiency as the consensus name of this fatty acid oxidation disorder

Molecular Genetics and Metabolism

Volumn 91, Issue 2, 2007, Pages 205-206

  He, Xue Ying ^a   Yang, Song Yu ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; LONG CHAIN HYDROXYACYL COENZYME A DEHYDROGENASE; MEDIUM CHAIN HYDROXYACYL COENZYME A DEHYDROGENASE; SHORT CHAIN HYDROXYACYL COENZYME A DEHYDROGENASE; UNCLASSIFIED DRUG;

ENZYME ACTIVITY; ENZYME DEFICIENCY; FAMILIAL DISEASE; FATTY ACID OXIDATION; GENE; GENE MUTATION; HADH GENE; HUMAN; HYPOGLYCEMIA; LETTER; METABOLIC DISORDER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REYE SYNDROME;

3-HYDROXYACYL COA DEHYDROGENASES; HUMANS; TERMINOLOGY;

EID: 34248532398     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2007.02.015     Document Type: Letter

References (10)

1. Bennett M.J., Russell L.K., Tokunaga C., Narayan S.B., Tan L., Seegmiller A., Boriak R.L., and Strauss A.W. Reye-like syndrome resulting from mutations in mitochondrial medium- and short-chain l-3-hydroxyacyl-CoA dehydrogenase. Mol. Genet. Metab. 89 (2006) 74-79
2. Yang S.Y., and He X.Y. Molecular mechanisms of the fatty acid β-oxidation enzyme catalysis. Adv. Exp. Med. Biol. 466 (1999) 133-143
3. Liang X., Le W., Zhang D., and Schulz H. Impact of the intramitochondrial enzyme organization on fatty acid oxidation. Biochem. Soc. Trans. 29 (2001) 279-282
4. Vredendaal P.J.C.M., van den Berg I.E.T., Malingre H.E.M., Stroobants A.K., OldeWeghuis D.E.M., and Berger R. Human short-chain l-3-hydroxyacyl-CoA dehydogenase: cloning and characterization of the coding sequence. Biochem. Biophys. Res. Commun. 223 (1996) 718-723
5. Tien I., De Vivo D.C., Hale D.E., Clarke J.T.R., Zinman H., Laxer R., Shore A., and DiMauro S. Short-chain l-3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: a new cause of recurrent myoglobinuria and encephalopathy. Ann. Neurol. 30 (1991) 415-419
6. Yang S.Y. The large subunit of the pig heart mitochondrial membrane-bound ß oxidation complex is a long-chain enoyl-CoA hydratase:3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme. Comp. Biochem. Physiol. 109B (1994) 557-566
7. Korman S.H., and Yang S.Y. HSD17B10 replaces HADH2 as the approved designation for the gene mutated in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency. Mol. Genet. Metab. 90 (2007) 10.1016/j.ymgme.2007.01.001
8. Yang S.Y., He X.Y., and Schulz H. 3-Hydroxyacyl-CoA dehydrogenase and short-chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease. FEBS J. 272 (2005) 4874-4883
9. He X.Y., and Yang S.Y. Roles of type 10 17beta-hydroxysteroid dehydrogenase in intracrinology and metabolism of isoleucine and fatty acids. Endocr. Metab. Immune Disord. Drug Targets 6 (2006) 95-102
10. Yang S.Y., He X.Y., and Schulz H. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase. Trends Endocrinol. Metab. 16 (2005) 167-175